nafamostat has been researched along with Cancer of Gallbladder in 2 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gemcitabine is an effective chemotherapeutic agent for advanced gallbladder cancer." | 1.39 | Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation. ( Fujiwara, Y; Furukawa, K; Haruki, K; Iwase, R; Misawa, T; Ohashi, T; Shiba, H; Uwagawa, T; Yanaga, K, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takada, N | 1 |
| Sugano, H | 1 |
| Shirai, Y | 1 |
| Saito, N | 1 |
| Hamura, R | 1 |
| Taniai, T | 1 |
| Uwagawa, T | 2 |
| Yanaga, K | 2 |
| Ikegami, T | 1 |
| Ohashi, T | 2 |
| Eto, K | 1 |
| Iwase, R | 1 |
| Haruki, K | 1 |
| Fujiwara, Y | 1 |
| Furukawa, K | 1 |
| Shiba, H | 1 |
| Misawa, T | 1 |
2 other studies available for nafamostat and Cancer of Gallbladder
| Article | Year |
|---|---|
Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells.
Topics: Animals; Apoptosis; Benzamidines; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Moda | 2021 |
Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Benzamidines; Carcinoma; Cell Line, Tumor; Cell | 2013 |